title: Effect of Hypertonic Saline Infusion versus Normal Saline on Serum NGAL and Cystatin C Levels in Patients Undergoing Coronary Artery Bypass Graft.
abstract: BACKGROUND
  Acute kidney injury (AKI) is a common and life-threatening complication following coronary artery bypass graft (CABG). Neutrophil gelatinase-associated lipocalin (NGAL) and Cystatin C have shown to be good predictive factors for AKI. Recently, there has been a growing interest in the use of hypertonic saline in cardiac operations. The purpose of this study was to evaluate the prophylactic anti-inflammatory effect of hypertonic saline (Group A) infusion versus normal saline (Group B) on serum NGAL and Cystatin C levels as the two biomarkers of AKI in CABG patients.
  
  
  METHODS
  This randomized double-blinded clinical trial recruited 40 patients undergoing CABG in Tehran Heart Center, Tehran, Iran. After applying exclusion criteria, the effects of preoperative hypertonic saline (294 meq Na) versus normal saline (154 meq Na) infusion on serum NGAL and Cystatin C levels were investigated in three intervals: before surgery and 24 and 48 hours postoperatively. The probable intraoperative or postoperative confounders, including pump time, cross-clamp time, heart rate, systolic and diastolic blood pressures, central venous pressure, arterial pH, partial pressure of arterial oxygen, fraction of inspired oxygen, blood sugar, Na, K, Mg, hemoglobins, white blood cells, hematocrits, and platelets, were recorded and compared between the two groups of study.
  
  
  RESULTS
  The study population comprised 40 patients, including 25 (62.5%) males, at a, mean age ± SD of 61.75 ± 8.13 years. There were no statistically significant differences between the patients' basic, intraoperative, and postoperative characteristics, including intraoperative and postoperative hemodynamic variables and supports such as inotropic use. Intra-aortic balloon pump use and mortality were not seen in our cases. Three patients in the normal saline group and one patient in the hypertonic saline group had serum NGAL levels greater than 400 ng/ml. Moreover, 10 patients in Group A and 17 patients in group B showed a rise in serum Cystatin C levels above 1.16 mg/dl. Patients with AKI had significantly elevated NGAL and Cystatin C levels (p value < 0.001), but there were no significant differences in the decrease in the NGAL level in the hypertonic saline group versus the normal saline group (230.91 ± 92.68 vs. 239.74 ± 116.58 ng/ml, respectively; p value = 0.792), or in the decrease in the Cystatin C level in the hypertonic saline group versus the normal saline group (1.05 ± 0.26 vs. 1.06 ± 0.31, respectively; p value = 0.874).
  
  
  CONCLUSIONS
  Pre-treatment of CABG patients with hypertonic saline had no significant effect on serum NGAL and Cystatin C levels compared to the normal saline-receiving group. Our present data, albeit promising, have yet to fully document outcome differences.
authors: Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
authors: Fardin
authors: F
authors: Yousefshahi
authors: Mona
authors: M
authors: Bashirzadeh
authors: Mohammad
authors: M
authors: Abdollahi
authors: Mojtaba
authors: M
authors: Mojtahedzadeh
authors: Abbass
authors: A
authors: Salehiomran
authors: Arash
authors: A
authors: Jalali
authors: Mahnaz
authors: M
authors: Mazandarani
authors: Elmira
authors: E
authors: Zaare
authors: Mehdi
authors: M
authors: Ahadi
keywords: Acute, kidney injury; Coronary artery bypass; Cystatin C; Neutrophil gelatinase-associated lipocalin protein, rat; Saline solution, hypertonic
references: Kidney Int. 1996 Sep;50(3):811-8
references: 8872955
references: J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):916-20
references: 19293171
references: Clin J Am Soc Nephrol. 2010 Sep;5(9):1552-7
references: 20538834
references: J Trauma. 2010 May;68(5):1172-7
references: 20453771
references: J Biol Chem. 1994 Jun 17;269(24):16712-9
references: 8206992
references: Expert Opin Med Diagn. 2008 Apr;2(4):387-398
references: 19079800
references: Ann Intern Med. 2008 Jun 3;148(11):810-9
references: 18519927
references: J Am Soc Nephrol. 2005 Nov;16(11):3365-70
references: 16177006
references: Crit Care Med. 1999 Oct;27(10):2159-65
references: 10548199
references: Nephrol Dial Transplant. 2008 Jun;23(6):1970-4
references: 18178605
references: Lancet. 2005 Apr 2-8;365(9466):1231-8
references: 15811456
references: Ann Surg. 2006 Jan;243(1):47-57
references: 16371736
references: JAMA. 2010 Oct 6;304(13):1455-64
references: 20924011
references: Zentralbl Chir. 1993;118(5):257-63; discussion 264-6
references: 7686707
references: Clin Nephrol. 1999 Dec;52(6):371-6
references: 10604645
references: Clinics (Sao Paulo). 2008 Dec;63(6):833-40
references: 19061009
references: Am J Kidney Dis. 2009 Dec;54(6):1012-24
references: 19850388
references: Am Heart J. 2004 Sep;148(3):430-8
references: 15389229
references: J Trauma. 2009 Aug;67(2):277-82
references: 19667879
references: Am J Surg. 2009 Sep;198(3):407-14
references: 19520355
references: Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Mar;23(3):150-3
references: 21366943
references: J Cardiovasc Pharmacol. 2009 Mar;53(3):261-6
references: 19247188
references: Crit Care Med. 2009 Feb;37(2):553-60
references: 19114878
references: J Am Soc Nephrol. 2004 Jun;15(6):1597-605
references: 15153571
references: Shock. 2011 Nov;36(5):435-9
references: 21841534
references: Crit Care Med. 2004 Mar;32(3):755-9
references: 15090958
references: Minerva Anestesiol. 2011 Oct;77(10):993-1002
references: 21952600
references: J Am Soc Nephrol. 2006 Nov;17(11):3132-8
references: 17021268
references: Kidney Int. 2004 Sep;66(3):1115-22
references: 15327406
references: Am J Med. 1998 Apr;104(4):343-8
references: 9576407
references: Crit Care. 2004 Aug;8(4):R204-12
references: 15312219
references: Eur J Anaesthesiol. 2001 Feb;18(2):100-7
references: 11270018
references: Kidney Int. 2006 Sep;70(6):1120-6
references: 16850028